Rechercher des projets européens

Plus de 40 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

Crimean-Congo Haemorrhagic Fever Vaccine (CCHFVaccine)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2022,

...s adequately understood, v) to perform clinical trials at Phase I and ensure a strategy for the effective deployment and utilization in resource-poor countries, and vi) to link this project to public health bodies, NGOs and vaccine companies. The proposed CCHFVaccine project will succeed in bringing together selected competitive advantages such as: operating capacity with appropriate facilities (s ...
Voir le projet

 15

 TERMINÉ 
...p to 2030 recognises the severity of P. vivax malaria and calls for a vaccine intervention to achieve 75% efficacy over two years – equally weighted with P. falciparum. However, despite this global health need, efforts to develop interventions against this parasite have lagged far behind those for P. falciparum, in large part because of critical bottlenecks in the vaccine development process. Thes ...
Voir le projet

 9

 TERMINÉ 

European Human Biomonitoring Initiative (HBM4EU)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2021,

The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts and will communicate with policy makers to ensure that our results are exploited in the design of new chemicals policies an ...
Voir le projet

 43

 TERMINÉ 

Optimizing a deployable high efficacy malaria vaccine (OptiMalVax)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2021,

...companies helping enhance Europe’s leading position in the commercial development of vaccines.This ambitious and exciting programme should have a high chance of success in tackling the major global health problem posed by malaria.
Voir le projet

 17

 TERMINÉ 
ERA-HDHL is a proposal of ERA-NET Cofund in the field of nutrition and health to support the Joint Programme Initiative Healthy Diet for a Healthy Life (JPI HDHL).Nowadays, there is a high burden of non-communicable diseases due to unhealthy diet and lifestyle patterns. The 24 members of the JPI HDHL are working together to develop means to (1) motivate people to adopt healthier lifestyles includi ...
Voir le projet

 19

 TERMINÉ 
All chemicals whether they are drugs, cosmetics, agrochemicals or others need to be tested for their safety to man and the environment. The use of whole animal studies for the prediction of adverse effects in man, is problematic due to species dependent effects, high costs and a large burden to animals in terms of numbers and suffering. While there have been major improvements in human in vitro a ...
Voir le projet

 14

 TERMINÉ 
The proposed European Concerted Programme on Radiation Protection Research (acronym: CONCERT) aims to contribute to the sustainable integration of European and national research programmes in radiation protection. It will do so by focusing resources and efforts in five key directions:• Bring together the elements of the European scientific communities in the fields of radiation effects and risks, ...
Voir le projet

 36

 TERMINÉ 

Meaningful Integration of Data, Analytics and Services (MIDAS)

Date du début: 1 nov. 2016, Date de fin: 29 févr. 2020,

The MIDAS consortium is a partnership involving health authorities in five EU countries and the U.S. and technical big data experts from research institutions, MNCs and SMEs. Managing big data for ‘health in all’ is a monumental challenge for policy makers. MIDAS is addressing this challenge by developing and delivering an integrated solution which will liberate knowledge from data silos and unify ...
Voir le projet

 17

 TERMINÉ 
Background: Influenza viruses cause annual epidemic and occasional pandemics, both of which induce significant morbidity and mortality. Influenza infections affect all age groups but children and adults over the age of 65 are at most risk of developing severe disease.Vaccination is the most effective approach to reduce the impact of annual influenza outbreaks and potential pandemics, however, the ...
Voir le projet

 26

 TERMINÉ 
...ers and SMEs, suppliers, operators and research organisations,3. Develop, upgrade and integrate 78 new connectable and interoperable tools, 4. Conduct 5 large scale demonstrations on the field: o health disaster in Africa (Epidemics in Guinea, with strong social and cultural issues),o natural disaster in a politically complex region and a desert environment (Earthquake in the Jordan Valley, led ...
Voir le projet

 29

 TERMINÉ 

Remotely Operated CBRNe Scene Assessment Forensic Examination (ROCSAFE)

Date du début: 1 juil. 2016, Date de fin: 30 juin 2019,

The overall goal of ROCSAFE is to fundamentally change how CBRNe events are assessed, in order to and ensure the safety of crime scene investigators by reducing the need for them to enter high-risk scenes when they have to determine the nature of threats and gather forensics. For this, ROCSAFE will make use of cost-effective modern remotely-controlled robotic air and ground vehicles (RAVs/RGVs) th ...
Voir le projet

 14

 TERMINÉ 

European Virus Archive goes global (EVAg)

Date du début: 1 avr. 2015, Date de fin: 31 mars 2019,

...ion of mammalian viruses in the world and move beyond the current state-of-the-art to provide an increasingly valuable resource and service to the world’s scientific community, including government health departments, higher education institutes, industry and, through information systems, the general public.
Voir le projet

 27

 TERMINÉ 

Eliciting Mucosal Immunity to Tuberculosis (EMI-TB)

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2018,

Tuberculosis (TB) is a global health problem, killing 1.5 million of people every year. The only currently available vaccine, Mycobacterium bovis BCG, is effective against severe childhood forms, but it demonstrates a variable efficacy against the pulmonary form of TB in adults. Many of these adult TB cases result from the reactivation of an initially controlled, latent Mycobacterium tuberculosis ...
Voir le projet

 15

 TERMINÉ 
The EU population is increasingly exposed to new physical and chemical agents in the environment, some of which may be detrimental to public health. Of these, electromagnetic fields (EMF) are one of the most ubiquitous, with new EMF technologies and novel applications being actively developed and commercialised. To address pertinent questions on EMF and health, GERoNiMO proposes an integrated appr ...
Voir le projet

 27

 TERMINÉ 
The TBVAC2020 proposal builds on the highly successful and long-standing collaborations in subsequent EC-FP5-, FP6- and FP7-funded TB vaccine and biomarker projects, but also brings in a large number of new key partners from excellent laboratories from Europe, USA, Asia, Africa and Australia, many of which are global leaders in the TB field. This was initiated by launching an open call for Express ...
Voir le projet

 49

 TERMINÉ 
...ct addresses existing approaches aiming to prevent lung diseases caused by tobacco while at the same time it develops new treatments and analyzes their contextual adaptability to the local and global health care system. SmokeFreeBrain follows an interdisciplinary approach exploiting consortium’s expertise in various relevant fields in order to generate new knowledge. State of the art techniques in ...
Voir le projet

 14

 TERMINÉ 
...ative treatments), as well as committed IRDiRC funding partners and representatives of all major international RD initiatives (EU/US/AU/JP) spanning patient organisations, research and public health, to maximise impact to RD patients
Voir le projet

 30

 TERMINÉ 
The I-MOVE+ Consortium includes European Union (EU) Public Health Institutes, SME and Universities. It aims at measuring and comparing the effectiveness (VE) and impact (VI) of influenza and Pneumococcal vaccines and vaccination strategies a in the elderly population in Europe. The goal is to develop a sustainable platform of primary care practices, hospitals and laboratory networks that share val ...
Voir le projet

 33

 TERMINÉ 

MIND

Date du début: 31 juil. 2015, Date de fin: 31 août 2018,

Zowel in Duitsland als in Nederland is de Life Science & Health sector een innovatieve sector met veel groeipotentieel voor de toekomst. Daarbij heeft de zorg ook te maken met grote maatschappelijke uitdagingen. Denk bijvoorbeeld aan de vergrijzing en nieuwe ziektebeelden. In het Duits- Nederlandse grensgebied is veel kennis op het gebied van Life Science & Health. Er zijn in beide landen verschil ...
Voir le projet

 29

 TERMINÉ 
"For a vast amount of applications in the medical, industrial, research and other sectors, a good understanding of radiation protection (RP) is fundamental in order to protect workers, the public and the environment from the potential risks of ionising radiation. Within this perspective, building and maintaining an advanced level of competence in RP, assuring sufficient well-trained personnel and ...
Voir le projet

 14

 TERMINÉ 

Shaping EUROpean policies to promote HEALTH equitY (EURO-HEALTHY)

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2017,

Health inequities have been increasing in Europe, particularly in a context of an ageing society and economic crisis. In countries with different levels of infrastructures and health system preparedness, inequities create significant policy challenges.The main goal of this project is to advance knowledge of policies that have the highest potential to enhance health and health equity across Europea ...
Voir le projet

 15

 TERMINÉ 
Sample return missions (SRMs) are a critical next step in our exploration of the Solar System and are identified as strategic missions by international space agencies. Europe has a very strong legacy in the curation and research of precious extraterrestrial materials. To maintain European leadership and ensure high-level involvement in future SRMs, a dedicated European Sample Curation Facility (ES ...
Voir le projet

 14

 TERMINÉ 
...nd require regular updating, the development of a “universal” influenza vaccine that can provide broad coverage against different strains within a subtype or even across subtypes has become a key health care priority in both industrialized and low and middle income countries. EDUFLUVAC aims to develop an influenza vaccine that educates the immune system to recognise common influenza epitopes, usin ...
Voir le projet

 9

 TERMINÉ 
Vitamin D deficiency has significant implications for human health and impacts on healthy growth and development and successful aging. Fundamental knowledge gaps are barriers to implementing a safe and effective public health strategy to prevent vitamin D deficiency and optimize status. ODIN will provide the evidence to prevent vitamin D deficiency in Europe and improve nutrition and public health ...
Voir le projet

 32

 TERMINÉ 
PANDHUB will create an integrated toolbox to aid transport operators and relevant actors in major transport hubs in the development of their current pandemic and dangerous pathogen preparedness and response plans. The project is intended to cover the extraordinary aspects specific to serious natural or man-made pathogen threats in the transport environment by providing accurate, reliable and valid ...
Voir le projet

 9

 TERMINÉ 
Drug development in TB requires new integrated methods to transition the novel combination regimens needed to shorten first-line therapy and combat multi-drug resistance. Although new agents are emerging, the path to registration of such regimens remains uncertain while capacity for pivotal trials is limited. Selection and optimization of drug combinations for development depends on preclinical sy ...
Voir le projet

 23

 TERMINÉ 

Advanced Immunization Technologies (ADITEC)

Date du début: 1 oct. 2011, Date de fin: 30 sept. 2017,

Vaccines so far have been developed mostly by following an empiric approach. To prevent and possibly cure unresolved and emerging infectious diseases we need to fully exploit the potential of the human immune system. Progress in science and technology makes it possible to achieve what was previously deemed impossible. The scope of this project is to produce knowledge necessary to develop novel and ...
Voir le projet

 53

 TERMINÉ 

Universal Influenza Vaccines Secured (UNISEC)

Date du début: 1 oct. 2013, Date de fin: 30 sept. 2017,

UNISEC brings together a European consortium of 3 University partners, 5 National Health Institutes and 3 SMEs, all with leading expertise in influenza vaccine research and development, to work on promising recently developed concepts for a universal influenza vaccine. The consortium is exceptionally strong, interdisciplinary and intersectional in nature, and encompasses a unique combination of sc ...
Voir le projet

 15

 TERMINÉ 

Innovation in teaching, training and dissemination of virology

Date du début: 1 sept. 2014, Date de fin: 31 août 2017,

...al media as a tool for educating. This will result in better prepared professionals able to confront more effectively the challenges posed by viruses in our society and the impacts that has on public health, the environment, and on the economics of disease burden and the relevance in agricultural, veterinary and medical aspects. A final and important long term benefit will be an improvement to the ...
Voir le projet

 8

 TERMINÉ 

Recognising Adverse Drug Reactions (WEB-RADR)

Date du début: 1 sept. 2014, Date de fin: 31 août 2017,

...ols delivered through WEB-RADR will be underpinned by extensive academic research and user testing to ensure the project meets the needs of all stakeholders, including patients.BackgroundReporting by healthcare professionals and patients by means of mobile devices and social media platforms to National Competent Authorities (NCAs) and marketing authorisation holders with subsequent transmission to ...
Voir le projet

 20

 TERMINÉ 

Global Research in Paediatrics (GRiP)

Date du début: 1 janv. 2011, Date de fin: 30 juin 2017,

Paediatric drugs (PD) lack appropriate testing. Most drugs have inadequate information about dosing regimen, dose adjustment and how to administer them. These are longstanding problems that unquestionably require concerted efforts at the international level. Both the US and the EU have introduced paediatric legislation that facilitates participation of children in research and pharmaceutical innov ...
Voir le projet

 24

 TERMINÉ 

European Research Infrastructure on Highly Pathogenic Agents 2 (ERINHA2)

Date du début: 1 janv. 2016, Date de fin: 30 juin 2017,

ERINHA2 aims to complete the work carried out during the first preparatory phase (PP1) - ERINHA - in order to reach the financial, administrative and technical maturity necessary to complete the establishment of the Research Infrastructre and ensure that the operation phase can begin in 2018. ERINHA2 will therefore finalise the decision to use the status of an association and prepare the necessary ...
Voir le projet

 17

 TERMINÉ 

Getting Nursing Experience in a Different Health Care System

Date du début: 1 juin 2015, Date de fin: 31 mai 2017,

The idea of the project „Getting Nursing Experience in a Different Health Care System” is to give nursing trainees - during their initial vocational training at the “Fachschule für Gesundheits- und Krankenpflege der Katholischen Kliniken im Märkischen Kreis” - the chance to work in a different healthcare-system for a period of four weeks. With the “DHSS Education and Training Centre” (Douglas / Is ...
Voir le projet

 2

 TERMINÉ 

Open Project for the European Radiation Research Area (OPERRA)

Date du début: 1 juin 2013, Date de fin: 31 mai 2017,

"Within the OPERRA project, it is proposed that the MELODI Association, as a well-advanced network, takes the lead in establishing the necessary structures able to manage the long-term European research programmes in radiation protection, also taking advantage of the valuable experience gathered through the DoReMi network of excellence. Whilst in fields adjacent to low-dose risk research (radioeco ...
Voir le projet

 71

 TERMINÉ 

European Multicentre Tics in Children Studies (EMTICS)

Date du début: 1 déc. 2011, Date de fin: 31 mai 2017,

This project will undertake pre-clinical and cohort studies that address susceptibility factors for paediatric and adolescent tic disorders, with a particular focus on comorbid obsessive-compulsive symptomatology, from clinical, epidemiological, genetic, microbiological and immunological angles. EMTICS aims to elucidate the complex aetiology of the onset and clinical course of chronic tic disorder ...
Voir le projet

 33

 TERMINÉ 

IMproving Preparedness and Response of HEalth Services in major criseS (IMPRESS)

Date du début: 1 mai 2014, Date de fin: 30 avr. 2017,

There exists a huge variety in the occurrence and characteristics of major incidents. Incident management stakeholders and in particular emergency health service providers have to deal with two basic challenges: The disproportion between the needs and the available human/material resources in the response capacity and the inherent time constraints of an emergency. These critical factors play a sem ...
Voir le projet

 12

 TERMINÉ 

Risk, Stem Cells and Tissue Kinetics – Ionising Radiation (RISK - IR)

Date du début: 1 nov. 2012, Date de fin: 30 avr. 2017,

The magnitude of cancer risk in humans exposed to low radiation doses (
Voir le projet

 16

 TERMINÉ 

Resistance in Gram-Negative Organisms: Studying Intervention Strategies (R-GNOSIS)

Date du début: 1 oct. 2011, Date de fin: 31 mars 2017,

Antibiotics are a mainstay of public health, but their use has increased exponentially leading to the emergence of antibiotic resistance. The R-GNOSIS (Resistance in Gram-Negative Organisms: Studying Intervention Strategies) project combines 5 international clinical studies, all supported by highly innovative microbiology, mathematical modelling and data-management, to determine - in the most rele ...
Voir le projet

 27

 TERMINÉ 

A common European approach to the regulatory testing of nanomaterials (NANOREG)

Date du début: 1 mars 2013, Date de fin: 28 févr. 2017,

The innovative and economic potential of Manufactured Nano Materials (MNMs) is threatened by a limited understanding of the related EHS issues. While toxicity data is continuously becoming available, the relevance to regulators is often unclear or unproven. The shrinking time to market of new MNM drives the need for urgent action by regulators. NANoREG is the first FP7 project to deliver the answe ...
Voir le projet

 73

 TERMINÉ 
...h activities in the field of socio-economic sciences and humanities. This may cover e.g. emerging drugs, vulnerable groups, changing demographics of drug using populations, and the impact of drugs on health inequalities and social deprivation. It may also cover patterns in drug markets and the drug-crime nexus. Closer cooperation between researchers in different countries will also lead to a furth ...
Voir le projet

 13